
Proteotype Launches €3 Million Study to Test Home-Based Cancer Detection
With €3.023 million in funding, Portuguese diagnostics firm Proteotype is launching the INNOVATOR clinical study to validate its Enlighten® cancer detection test across 12 different cancer types, while testing the viability of home-based capillary blood collection to replace traditional venous draws.
















.png)





